ZV

ZEISS Ventures

Europe, Baden-Wurttemberg, Germany, Oberkochen

Description

ZEISS Ventures is a cooperate venture arm of the ZEISS Group.

Investor Profile

ZEISS Ventures has made 3 investments, with 1 in the past 12 months and 100% as lead.

Stage Focus

  • Seed (33%)
  • Series Unknown (33%)
  • Series A (33%)

Country Focus

  • United Kingdom (33%)
  • Switzerland (33%)
  • Germany (33%)

Industry Focus

  • Health Care
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Biotechnology
  • Medical Device
  • Medical
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ZEISS Ventures frequently co-invest with?

IFB Innovationsstarter
Europe, Hamburg, Germany, Hamburg
Co-Investments: 1
AI.FUND
Europe, Hamburg, Germany, Hamburg
Co-Investments: 1
KHP Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
LE
North America, New York, United States, New York
Co-Investments: 1
EIC Accelerator
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
redalpine
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
HERAN Partners
Europe, Antwerpen, Belgium, Antwerp
Co-Investments: 1

What are some of recent deals done by ZEISS Ventures?

Surgify

Espoo, Southern Finland, Finland

Surgify develops new solutions to protect these structures and prevent associated complications. Bleeding, infections and nerve injuries.

CommercialHealth CareMedical
Series AMay 27, 2025
Amount Raised: $7,980,746
Mindpeak

Hamburg, Hamburg, Germany

Mindpeak develops and distributes AI-based diagnostic software for the detection, quantification, and classification of cancer.

Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningSoftware
Series ASep 30, 2024
Amount Raised: $15,300,000
Hypervision Surgical

London, England, United Kingdom

Making surgeries more precise, safer and faster. Guiding the future of surgery using AI-powered hyperspectral imaging.

Artificial Intelligence (AI)Health CareMachine LearningMedical Device
SeedJun 1, 2023
Amount Raised: $8,142,088
InSphero

Schlieren, Zurich, Switzerland

InSphero is a supplier of organotypic, biological, in vitro 3D microtissues for highly predictive drug testing.

BiotechnologyHealth CareMedical
Series UnknownMar 31, 2023